Literature DB >> 23833190

The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis.

Huarui Lu1, Timothy C Hallstrom.   

Abstract

The E2F1 transcription factor is active in many types of solid tumors and can function as either an oncogene or tumor suppressor in vivo. E2F1 activity is connected with a variety of cell fates including proliferation, apoptosis, senescence, differentiation, and autophagy, and these effects are mediated through differential target gene expression. E2F1-induced cell death is an innate anti-cancer mechanism to kill cells with a spontaneous oncogenic mutation that might otherwise form a cancer. Relatively little is known about the molecular circuitry that tips E2F1 balance toward proliferation during normal growth versus apoptosis during oncogenic stress, and which pathways mediate this decision. To further explore these mechanisms, we utilized an unbiased shRNA screen to identify candidate genes that mediate E2F1-induced cell death. We identified the ubiquitin-like with PHD and ring finger domains 2 (UHRF2) gene as an important mediator of E2F1-induced cell death. UHRF2 encodes a nuclear protein involved in cell-cycle regulation. Several of these domains have been shown to be essential for the regulation of cell proliferation, and UHRF2 has been implicated as an oncogene in some settings. Other reports have suggested that UHRF2 causes growth arrest, functions as a tumor suppressor, and is deleted in a variety of tumors. We show that UHRF2 is a transcriptional target of E2F, that it directly interacts with E2F1, and is required for E2F1 induction of apoptosis and transcription of a number of important apoptotic regulators.

Entities:  

Keywords:  Apoptosis; E2F Transcription Factor; Gene Expression; Transcription Target Genes; UHRF2; shRNA

Mesh:

Substances:

Year:  2013        PMID: 23833190      PMCID: PMC3745330          DOI: 10.1074/jbc.M112.447276

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

2.  Direct repression of the Mcl-1 promoter by E2F1.

Authors:  Rhonda Croxton; Yihong Ma; Lanxi Song; Eric B Haura; W Douglas Cress
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

3.  A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.

Authors:  Hidesato Ogawa; Kei-Ichiro Ishiguro; Stefan Gaubatz; David M Livingston; Yoshihiro Nakatani
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

4.  E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.

Authors:  Harry A Rogoff; Mary T Pickering; Michelle E Debatis; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

5.  S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.

Authors:  Jiqin Zhang; Qinqin Gao; Pishun Li; Xiaoli Liu; Yuanhui Jia; Weicheng Wu; Jiwen Li; Shuo Dong; Haruhiko Koseki; Jiemin Wong
Journal:  Cell Res       Date:  2011-11-08       Impact factor: 25.617

6.  Role of the p53-homologue p73 in E2F1-induced apoptosis.

Authors:  T Stiewe; B M Pützer
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

7.  Apaf-1 is a transcriptional target for E2F and p53.

Authors:  M C Moroni; E S Hickman; E Lazzerini Denchi; G Caprara; E Colli; F Cecconi; H Müller; K Helin
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

8.  Role for the p53 homologue p73 in E2F-1-induced apoptosis.

Authors:  M Irwin; M C Marin; A C Phillips; R S Seelan; D I Smith; W Liu; E R Flores; K Y Tsai; T Jacks; K H Vousden; W G Kaelin
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

9.  A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.

Authors:  N A Lissy; P K Davis; M Irwin; W G Kaelin; S F Dowdy
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

10.  Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation.

Authors:  Scott B Rothbart; Krzysztof Krajewski; Nataliya Nady; Wolfram Tempel; Sheng Xue; Aimee I Badeaux; Dalia Barsyte-Lovejoy; Jorge Y Martinez; Mark T Bedford; Stephen M Fuchs; Cheryl H Arrowsmith; Brian D Strahl
Journal:  Nat Struct Mol Biol       Date:  2012-09-30       Impact factor: 15.369

View more
  17 in total

1.  HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.

Authors:  Fengjuan Cheng; Guanhua Qian; Xianyun Fang; Jingjie Sun; Siyuan Chen; Rongjuan Chen; Shangjing Liu; Zhaodi Li; Kejia Wu; Shiming Jiang; Yong Chen; Ni Tang; Juan Chen; Changzhu Duan
Journal:  Hepatol Int       Date:  2021-04-19       Impact factor: 6.047

2.  Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.

Authors:  Dhiraj Sikaria; Yaping N Tu; Diana A Fisler; James A Mauro; George Blanck
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-05       Impact factor: 4.553

3.  Elucidating feed-forward apoptosis signatures in breast cancer datasets: Higher FOS expression associated with a better outcome.

Authors:  Diana A Fisler; Dhiraj Sikaria; John M Yavorski; Yaping N Tu; George Blanck
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

4.  TCGA: Increased oncoprotein coding region mutations correlate with a greater expression of apoptosis-effector genes and a positive outcome for stomach adenocarcinoma.

Authors:  John M Yavorski; George Blanck
Journal:  Cell Cycle       Date:  2016-06-29       Impact factor: 4.534

5.  UHRF2 regulates cell cycle, epigenetics and gene expression to control the timing of retinal progenitor and ganglion cell differentiation.

Authors:  Xiaohong Wang; Aaron L Sarver; Qiyuan Han; Christopher L Seiler; Chencheng Xie; Huarui Lu; Colleen L Forster; Natalia Y Tretyakova; Timothy C Hallstrom
Journal:  Development       Date:  2022-03-14       Impact factor: 6.862

6.  Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells.

Authors:  Aaron L Sarver; Chencheng Xie; Megan J Riddle; Colleen L Forster; Xiaohong Wang; Huarui Lu; Wyatt Wagner; Jakub Tolar; Timothy C Hallstrom
Journal:  Lab Invest       Date:  2021-03-03       Impact factor: 5.662

7.  E2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional Program.

Authors:  Xiaolei Jiang; Joseph Roy Nevins; Igor Shats; Jen-Tsan Chi
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

8.  Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice.

Authors:  Emma A Filtz; Ann Emery; Huarui Lu; Colleen L Forster; Chris Karasch; Timothy C Hallstrom
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

9.  Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.

Authors:  Chencheng Xie; Huarui Lu; Alice Nomura; Eric Allan Hanse; Colleen Lynn Forster; Josh Berken Parker; Michael Andrew Linden; Chris Karasch; Timothy Curtis Hallstrom
Journal:  Mol Cancer       Date:  2015-04-24       Impact factor: 27.401

10.  Quantitative Identification of Compound-Dependent On-Modules and Differential Allosteric Modules From Homologous Ischemic Networks.

Authors:  B Li; J Liu; Y Y Zhang; P Q Wang; Y N Yu; R X Kang; H L Wu; X X Zhang; Z Wang; Y Y Wang
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.